Plasminogen activator inhibitor 1 (SERPINE1, also known as PAI-1), is considered as a prognostic biomarker for gastric cancer, gliomas, and colorectal cancer [40–42], hepatocellular carcinoma [43]. This evidence concerns the gene SERPINE1 and glioma.